Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
:PLX
Protalix (PLX) Ownership Overview
3.84% Insiders
2.79% Mutual Funds
4.60% Other Institutional Investors
3.77% ETFs
85.00% Public Companies and Individual Investors
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 11.16% of the company’s stock is owned by Institutional Investors, 3.84% is owned by Insiders, and 85.00% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 19, 2025 | xxxxxxxxxxxxx | $314 | |
Aug 12, 2025 | xxxxxxxxxxxxx | $205110 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,476,934 | Insider | 3.11% | 4,607,097 | |
| 2,412,794 | Institution | 3.03% | 4,487,797 | |
| 748,553 | Institution | 0.94% | 1,392,309 | |
| 399,051 | Institution | 0.50% | 742,235 | |
| 390,853 | Institution | 0.49% | 726,987 | |
| 341,207 | Institution | 0.43% | 634,645 | |
| 310,500 | Insider | 0.39% | 577,530 | |
| 272,942 | Institution | 0.34% | 507,672 | |
| 232,929 | Insider | 0.29% | 433,248 | |
| 180,000 | Institution | 0.23% | 334,800 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 748,553 | Institution | 0.94% | 1,392,309 | |
| 390,853 | Institution | 0.49% | 726,987 | |
| 341,207 | Institution | 0.43% | 634,645 | |
| 272,942 | Institution | 0.34% | 507,672 | |
| 180,000 | Institution | 0.23% | 334,800 | |
| 175,070 | Institution | 0.22% | 325,630 | |
| 28,351 | Institution | 0.04% | 52,733 | |
| 23,784 | Institution | 0.03% | 44,238 | |
| 13,641 | Institution | 0.02% | 25,372 | |
| 13,514 | Institution | 0.02% | 25,136 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,655,745 | Institution | 2.08% | 3,195,588 | |
| 587,914 | Institution | 0.74% | 1,134,674 | |
| 332,703 | Institution | 0.42% | 738,601 | |
| 169,135 | Institution | 0.21% | 326,431 | |
| 60,823 | Institution | 0.08% | 135,027 | |
| 32,253 | Institution | 0.04% | 62,248 | |
| 15,471 | Institution | 0.02% | 29,859 | |
| 7,085 | Institution | <0.01% | 13,674 | |
| 6,205 | Institution | <0.01% | 11,975 | |
| 5,525 | Institution | <0.01% | 12,266 |
FAQ
Who Owns Protalix Biotherapeutics (PLX)?
According to the latest TipRanks data, approximately 4.60% of the company's stock is held by institutional investors, 3.84% is held by insiders, and 85.00% is held by retail investors.
What percentage of Protalix Biotherapeutics (PLX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.60% of Protalix Biotherapeutics (PLX) stock is held by institutional investors.
What percentage of Protalix Biotherapeutics (PLX) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.00% of Protalix Biotherapeutics (PLX) stock is held by retail investors.
Who owns the most shares of Protalix Biotherapeutics (PLX)?
Dror Bashan owns the most shares of Protalix Biotherapeutics (PLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.